M. C. Myzak, Orner, G. A., Ho, E., and Dashwood, R. H.,
“Sulforaphane suppresses tumorigenesis in Apcmin mice via inhibition of histone deacetylase”,
The Federation of American Societies for Experimental Biology, vol. 20, no. 3, pp. 506-8, 2006.
M. C. Myzak, Tong, P., Dashwood, W. M., Dashwood, R. H., and Ho, E.,
“Sulforaphane retards the growth of human PC-3 prostate cancer xenografts and inhibits HDAC activity in human subjects”,
Experimental Biology and Medics, vol. 232, no. 2, pp. 227-234, 2007.
M. C. Myzak, Hardin, K., Dashwood, R. H., and Ho, E.,
“Sulforaphane Inhibits Histone Deacetylase Activity in BPH-1, LnCaP, and PC-3 Prostate Epithelial Cells”,
Carcinogenesis, vol. 27, no. 4, pp. 811-819, 2006.
R. H. Dashwood, Myzak, M. C., and Ho, E.,
“Dietary HDAC inhibitors: Time to rethink weak ligands for cancer prevention”,
Carcinogenesis, vol. 27, no. 2, pp. 344-9, 2006.
M. C. Myzak, Ho, E., and Dashwood, R. D.,
“Dietary agents as histone deacetylase inhibitors”,
Molecular Carcinogenesis, vol. 45, no. 6, pp. 443-446, 2006.
OREGON STATE UNIVERSITY
Open search box
]